These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23919665)

  • 1. Rac1-mediated effects of HMG-CoA reductase inhibitors (statins) in cardiovascular disease.
    Adam O; Laufs U
    Antioxid Redox Signal; 2014 Mar; 20(8):1238-50. PubMed ID: 23919665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidative effects of statins.
    Adam O; Laufs U
    Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent development in the effects of statins on cardiovascular disease through Rac1 and NADPH oxidase.
    Kwok JM; Ma CC; Ma S
    Vascul Pharmacol; 2013 Jan; 58(1-2):21-30. PubMed ID: 23085091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment.
    Maack C; Kartes T; Kilter H; Schäfers HJ; Nickenig G; Böhm M; Laufs U
    Circulation; 2003 Sep; 108(13):1567-74. PubMed ID: 12963641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of statins.
    Liao JK; Laufs U
    Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of HMG CoA reductase inhibition on small GTPases in the heart.
    Laufs U; Kilter H; Konkol C; Wassmann S; Böhm M; Nickenig G
    Cardiovasc Res; 2002 Mar; 53(4):911-20. PubMed ID: 11922901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and myocardial hypertrophy.
    Nakagami H; Liao JK
    Coron Artery Dis; 2004 Aug; 15(5):247-50. PubMed ID: 15238820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms.
    Nakagami H; Jensen KS; Liao JK
    Ann Med; 2003; 35(6):398-403. PubMed ID: 14572163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and the myocardium.
    Mital S; Liao JK
    Semin Vasc Med; 2004 Nov; 4(4):377-84. PubMed ID: 15861318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Rac1 GTPase activation in atrial fibrillation.
    Adam O; Frost G; Custodis F; Sussman MA; Schäfers HJ; Böhm M; Laufs U
    J Am Coll Cardiol; 2007 Jul; 50(4):359-67. PubMed ID: 17659204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins inhibit beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes via a Rac1-dependent mechanism.
    Ito M; Adachi T; Pimentel DR; Ido Y; Colucci WS
    Circulation; 2004 Jul; 110(4):412-8. PubMed ID: 15262848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
    Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N
    J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rac-1 as a new therapeutic target in cerebro- and cardio-vascular diseases.
    Carrizzo A; Forte M; Lembo M; Formisano L; Puca AA; Vecchione C
    Curr Drug Targets; 2014; 15(13):1231-46. PubMed ID: 25345393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy for cardiac hypertrophy and heart failure.
    Liao JK
    J Investig Med; 2004 May; 52(4):248-53. PubMed ID: 15521546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.
    Custodis F; Eberl M; Kilter H; Böhm M; Laufs U
    Cardiovasc Res; 2006 Jul; 71(2):342-51. PubMed ID: 16698001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Rac and Rho hall of fame: a decade of hypertrophic signaling hits.
    Brown JH; Del Re DP; Sussman MA
    Circ Res; 2006 Mar; 98(6):730-42. PubMed ID: 16574914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential endothelial hydrogen peroxide signaling via Nox isoforms: Critical roles for Rac1 and modulation by statins.
    Waldeck-Weiermair M; Yadav S; Kaynert J; Thulabandu VR; Pandey AK; Spyropoulos F; Covington T; Das AA; Krüger C; Michel T
    Redox Biol; 2022 Dec; 58():102539. PubMed ID: 36401888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells.
    Whaley-Connell AT; Morris EM; Rehmer N; Yaghoubian JC; Wei Y; Hayden MR; Habibi J; Stump CS; Sowers JR
    Am J Nephrol; 2007; 27(1):15-23. PubMed ID: 17204833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling.
    Reil JC; Hohl M; Oberhofer M; Kazakov A; Kaestner L; Mueller P; Adam O; Maack C; Lipp P; Mewis C; Allessie M; Laufs U; Böhm M; Neuberger HR
    Cardiovasc Res; 2010 Aug; 87(3):485-93. PubMed ID: 20211865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.